BSX · News · 20260913N
Guidance / Outlook
BOSTON SCIENTIFIC CORP · 2026-09-13 · Importance 47 · Surprise 60 · In source text
A cyberattack on August 25, 2026 disrupted Boston Scientific’s manufacturing and shipping operations. Although operations have resumed, the company expects to miss its third-quarter and full-year 2026 guidance for net sales and adjusted earnings per share. The disruption creates near-term operational and outlook risk despite reported strong demand for products including Farapulse.
Key facts
- Boston Scientific now expects to miss its third-quarter and full-year 2026 guidance for net sales and adjusted earnings per share. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | negative | probable | — | Boston Scientific now expects to miss its third-quarter and full-year 2026 guidance for net sales and adjusted earnings per share. |
| net_income | negative | probable | — | Boston Scientific now expects to miss its third-quarter and full-year 2026 guidance for net sales and adjusted earnings per share. |